News
according to US government estimates. And with tariffs now looming the companies say they have even less incentive to invest in an increasingly uncompetitive European Union. Certainly Big Pharma ...
Reeves and the Government need ... a turbulent week for big pharma as Donald Trump questioned drug pricing in the US. Keir Starmer is so obsessed with keeping on good terms with the US President ...
For instance, according to the US Government ... very good at research, not necessarily at developing or commercialising their brands,” he said. “Conversely, when you are a big pharma company ...
Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its ... capital back to the company. Tax cuts good, tariffs bad: Pfizer CEO Albert Bourla ...
A survey of small-to-medium pharma companies ... or no confidence” in the government’s handling of Brexit negotiations, and nearly two-thirds believe a ‘good’ deal won’t be achieved ...
“In a room with the big leaguers of the FDA, I asked them what made them ... after two federal lawsuits waged by the OFA challenging the FDA’s decision were decided in favor of the government agency, ...
Stephen Saad, CEO and co-founder of Aspen Pharmacare, purchased just over R184.6 million in the company’s shares this week, ...
The Canadian government had imposed steep tariffs on such products ... indexed to inflation (currently $17.75 / hour); the beginnings of a national pharma-care program (to be negotiated with the ...
Both figures are slightly down on what was achieved in 2024, and there are good reasons for this ... This is at least encouraging. Most Big Pharma companies have been pledging to do more of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results